88420-24-0Relevant articles and documents
Fibrinogen receptor antagonists and their use
-
Page/Page column 100, (2010/08/04)
This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.
Thiadiazole compounds as antagonists of SRS-A
-
, (2008/06/13)
Novel heterocyclic compounds shown by the general formula STR1 or the pharmaceutically acceptable salts thereof useful as medicament in particular as antagonist of slow reacting substance of anaphylaxis (SRS-A).
DERIVATIVES OF 4-ACETYL-3-HYDROXY-2-ALKYL-PHENOXYCARBOXYLIC ACIDS
-
, (2008/06/13)
The invention relates to compounds of the formula STR1 wherein R is hydrogen or lower alkyl, Y is alkylene; Z is alkylene, STR2 the asterisk herein denotes bonding to the substituted acetophenone; R 2 is hydrogen or lower alkoxy; and n is an integer of 1